Breaking News
August 15, 2018 - Cardiac Profiles Up With Exercise, Less Sitting in Early Old Age
August 15, 2018 - Precision medicine offers a glimmer of hope for Alzheimer’s disease
August 15, 2018 - Immunovia’s new blood-based testing platform accurately detects non-small cell lung cancer
August 15, 2018 - New method provides a ‘big picture’ of genetic influences on traits and diseases
August 15, 2018 - Early Onset Type 1 Diabetes Linked to Heart Disease, Shorter Life
August 14, 2018 - SMURF1 provides targeted approach to preventing cocaine addiction relapse
August 14, 2018 - Genetic testing pushed for hereditary high cholesterol disease
August 14, 2018 - Researchers discover new genes involved in Alzheimer’s Disease
August 14, 2018 - Medicare to overhaul ACOs but critics fear fewer participants
August 14, 2018 - Adolescent health projects receive meager percentage of global funding, study finds
August 14, 2018 - University Hospitals Seidman Cancer Center launches new CAR-T therapy trial
August 14, 2018 - In the addiction battle, is forced rehab the solution?
August 14, 2018 - Busting myths about milk – Scope
August 14, 2018 - Platelet-rich plasma does not enhance cartilage formation capabilities of stem cells
August 14, 2018 - Wearable devices and ‘mhealth’ technology emerge as promising tools for better health
August 14, 2018 - Clinical study suggests new treatment direction for head and neck cancer in heavy smokers
August 14, 2018 - Phase 2 Clinical Data Published Showing Summit’s Ridinilazole Preserved Gut Microbiome of Patients with CDI
August 14, 2018 - Cardiac progenitor cells undergo a cell fate switch to build coronary arteries
August 14, 2018 - Study identifies potential guidance to treat gastric cancer patients
August 14, 2018 - Revealed: The molecular mechanism underlying hypertrophic cardiomyopathy, or “workaholic heart”
August 14, 2018 - Diabetes epidemic in Guatemala driven by aging, not obesity
August 14, 2018 - New technology shows potential to streamline the analysis of proteins
August 14, 2018 - Rethinking the stroke rule ‘time is brain’
August 14, 2018 - Incidence of coronary artery compression in children may be more common than previously thought
August 14, 2018 - Study helps to better understand disease caused by Alpha-1 antitrypsin deficiency
August 14, 2018 - AI platform identifies acute neurological illnesses faster than human diagnosis
August 14, 2018 - American College of Rheumatology receives grants to support development of lupus clinical trials
August 14, 2018 - New study explains why women get more migraines than men
August 14, 2018 - American Heart Association Urges Screen Time Limits for Youth
August 14, 2018 - Brief interventions during routine care reduce alcohol use among men with HIV
August 14, 2018 - New genome analysis could identify people at higher risk of common deadly diseases
August 14, 2018 - NIH grant for Mount Sinai to study use of inhaled corticosteroids for treatment of sickle cell disease
August 14, 2018 - Daicel supplies free nanodiamond samples to international researchers
August 14, 2018 - Switching anti-psychotic drugs in first-episode schizophrenia patients does not improve clinical outcomes
August 14, 2018 - Study to examine whether modulating gut bacteria can improve cardiac function in heart failure patients
August 14, 2018 - AI technology could hold key to improving health services
August 14, 2018 - One out of two children not getting enough nutrients needed for their health
August 14, 2018 - Mono-antiplatelet therapy after aortic heart valve replacements may work as well as two drugs
August 14, 2018 - Aid-in-dying patient chooses his last day
August 14, 2018 - Exercise Really Can Chase Away the Blues, to a Point
August 14, 2018 - Surgical mesh implants may cause autoimmune disorders
August 14, 2018 - Researchers develop revolutionary zebrafish model to gain more insight into bone diseases
August 14, 2018 - Researchers discover secret communication hotline between breast cancers and normal cells
August 14, 2018 - Study examines how a person adapts to visual field loss after stroke
August 14, 2018 - Researchers show how specialized nucleic acid-based nanostructures could help target cancer cells
August 14, 2018 - Reducing opioid prescriptions for one operation can also spill over to other procedures
August 14, 2018 - E-cigarettes not so safe but still better than cigarettes
August 14, 2018 - Researchers find link between common ‘harmless’ virus and cardiovascular damage
August 14, 2018 - Initiation of PIMs associated with higher risk of fracture-specific hospitalizations and mortality
August 14, 2018 - Genetically modified mosquitoes and special bed nets help tackle deadly diseases
August 14, 2018 - Advances in treating hep C lead to new option for transplant patients
August 14, 2018 - Study finds quality of doctor-patient discussions about lung cancer screening to be ‘poor’
August 14, 2018 - MSU researchers uncover the effects of aging on regenerative ability of kidneys
August 14, 2018 - Better conditioning, throwing mechanics can help reduce elbow injuries in young baseball pitchers
August 14, 2018 - Brain game doesn’t offer brain gain
August 14, 2018 - Reproductive choices facing women with disabilities require careful consideration
August 14, 2018 - Scientists pinpoint the cause of a rare childhood seizure disorder
August 14, 2018 - Lumpectomy plus radiation associated with reduced risk of breast cancer death, study finds
August 14, 2018 - UAB study shows how ion channel differentiates newborn and mature neurons in the brain
August 14, 2018 - Experts highlight key knowledge gaps that need to be addressed in Ebola vaccine research
August 14, 2018 - Discovery could lead to new drugs against infection and inflammation
August 14, 2018 - Infection Prevention Differs Between Small, Large Hospitals
August 14, 2018 - Mom still matters—In study, young adults tended to prioritize parents over friends
August 14, 2018 - Deep brain stimulation might benefit those with severe alcoholism, preliminary studies show
August 14, 2018 - Study finds increased rate of repeat pregnancies in women with intellectual and developmental disabilities
August 14, 2018 - Lighter sedation fails to reduce risk of postoperative delirium in older patients
August 13, 2018 - Asking better questions about person’s memory could improve doctors’ understanding of patients
August 13, 2018 - U.S. Trauma Doctors Push for Stricter Gun Controls
August 13, 2018 - Asthma and flu: a double whammy
August 13, 2018 - 5 Questions: Donna Zulman on engaging high-need patients in intensive outpatient programs | News Center
August 13, 2018 - Behavioral Nudges Lead to Drop in Prescriptions of Potent Antipsychotic
August 13, 2018 - Potential New Class of Drugs May Reduce Cardiovascular Risk by Targeting Gut Microbes
August 13, 2018 - How to get your kids to eat better
August 13, 2018 - The importance of hearing your patients
August 13, 2018 - Transmission of F. tularensis unlikely to happen through the food chain
August 13, 2018 - Researchers discover epigenetic mechanism underlying ischemic cardiomyopathy
August 13, 2018 - Adolescent health programs receive only a tiny share of international aid, finds research
August 13, 2018 - Fracture risk increases by 30% after gastric bypass, study shows
August 13, 2018 - Quality-improvement project to standardize feeding practices helps micro preemies gain weight
August 13, 2018 - Long-term cannabinoid exposure impairs memory, study shows
Death Rate Falls with Anti-TNF in Crohn’s

Death Rate Falls with Anti-TNF in Crohn’s

image_pdfDownload PDFimage_print

Action Points

  • Patients with Crohn’s disease (CD) treated with tumor necrosis factor (TNF) inhibitors had a statistically significant reduction in mortality relative to those treated with prolonged corticosteroid therapy, in a large retrospective study.
  • Note that the association of anti-TNF therapy and reduced mortality was in the same direction but not statistically significant among patients with ulcerative colitis (UC).

Patients with Crohn’s disease who were treated with tumor necrosis factor (TNF) inhibitors had a lower mortality risk than those who had prolonged corticosteroid therapy, a large retrospective cohort study found.

Among 1,879 Crohn’s patients initiating anti-TNF therapy, there was a significantly lower risk of death (OR 0.78, 95% CI 0.65-0.93) compared with risks for 7,694 patients treated with long-term steroids, according to James D. Lewis, MD, director of the Gastroenterology and Hepatology Clinical Research Program at the University of Pennsylvania in Philadelphia, and colleagues.

And while the mortality risk was numerically lower for patients with ulcerative colitis receiving anti-TNF treatment (n=459), the difference compared with steroid users (n=3,224) was not statistically significant (OR 0.87, 95% CI 0.63-1.22), the researchers reported in the American Journal of Gastroenterology.

“The reduced mortality rates among patients with Crohn’s disease was potentially a consequence of excess cardiovascular-related mortality and hip fractures and was largely limited to patients with multiple or serious comorbid conditions.”

Corticosteroids and anti-TNF therapies both are widely used in the treatment of inflammatory bowel disease, but both approaches are associated with potentially serious — and even fatal — adverse events, the team explained. Both classes of drugs are associated with serious infections and congestive heart failure, anti-TNFs have been linked with cancer, and corticosteroids are associated with pulmonary embolism and osteoporosis/fractures. Moreover, uncontrolled disease may itself raise the mortality risk.

Previous studies have demonstrated an increased mortality risk among patients with inflammatory bowel disease treated with corticosteroids, but studies assessing anti-TNF therapy have not had clear-cut results. Previous work also has not considered potentially important factors such as comorbid illness and older age in evaluating risk of death.

Lewis and colleagues therefore analyzed outcomes among patients with inflammatory bowel disease enrolled in Medicare from 2006 to 2013 and in Medicaid from 2001 to 2005.

The anti-TNF group included those who had at least one prescription for infliximab (Remicade), adalimumab (Humira), or certolizumab pegol (Cimzia) during the previous year, while the prolonged corticosteroid group included those with at least 3,000 mg prednisone or 600 mg of budesonide exposure within the past 12 months.

The primary outcome was all-cause mortality, and secondary endpoints included major adverse cardiovascular events, cancer, hip fracture, pulmonary embolism, serious infection, and emergency bowel resection. The analysis was conducted using marginal structural models and propensity scoring.

Total follow-up times among the Crohn’s disease patients were 6,222 person-years in the anti-TNF group and 24,625 person-years in the prolonged steroid group, while the corresponding numbers for ulcerative colitis were 1,213 and 9,158 person-years, respectively.

During follow-up, 1,444 patients died, with mean ages at death of 67 for patients with Crohn’s disease and 76.7 for those with ulcerative colitis.

The weighted annual incidence of death among patients with Crohn’s disease was 21.4 per 1,000 patients in the anti-TNF group and 30.1 per 1,000 in the prolonged steroid group. For ulcerative colitis, the corresponding numbers were 23 and 30.9 per 1,000, respectively.

The association between anti-TNF use and mortality risk did not differ according to age, but the lower mortality was seen only among patients with comorbidity scores higher than 3, with odds ratios of 0.65 (95% CI 0.48-0.88) for Crohn’s disease and 0.63 (95% CI 0.36-1.11) for ulcerative colitis.

For secondary endpoints among Crohn’s disease patients, anti-TNF therapy was associated with decreased risks of major adverse cardiovascular events (OR 0.68, 95% CI 0.55-0.85) and hip fracture (OR 0.54, 95% CI 0.34-0.83), although these decreased risks were not seen in patients with ulcerative colitis.

The observation that the risk of major adverse cardiovascular events was not decreased in patients with ulcerative colitis may be explained by the fact that systemic inflammation is more common in Crohn’s disease than in ulcerative colitis, the authors noted.

Hospitalizations for inflammatory bowel disease were somewhat more common in the anti-TNF group for both Crohn’s disease (OR 1.13, 95% CI 1.04-1.23) and ulcerative colitis (OR 1.53, 95% CI 1.29-1.81).

The observation that lower mortality rates seen in this analysis appeared to relate to cardiovascular disease and hip fracture as well as to the presence of serious or multiple comorbidities may have implications for treatment, the team said. Such a patient population, “which is rarely included in clinical trials and for whom some physicians may be reluctant to treat with chronic immunosuppression, may be particularly good candidates for anti-TNF agents such as corticosteroid-sparing therapy.”

Limitations of the study, the researchers said, included its residual confounding and reliance on administrative data.

The study was funded by the Patient Centered Outcomes Research Institute (PCORI).

The authors reported financial relationships with Celgene, Shire, Janssen, AbbVie, Immune Pharmaceuticals, AstraZeneca, Amgen, MedImmune, Merck, Nestle Health Science, Takeda, Pfizer, Ili Lilly, Gilead, Samsung Bioepis, Johnson & Johnson, Lycera, Evidera, GlaxoSmithKline, Janssen, Bristol-Myers Squibb, UCB, and Crescendo.

2018-01-24T14:00:00-0500

Tagged with:

About author

Related Articles